PressSeptember 1, 2021 Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit
PressAugust 26, 2021 Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling Addiction Led by Professor Celia Morgan
PressAugust 26, 2021 PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study
Psychedelic NewsAugust 26, 2021 Mycelial Gallery Blends Crypto and Psychedelics to Raise Money For MAPS; Donates $108k
PressAugust 25, 2021 Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida
PressAugust 24, 2021 MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders
PressAugust 24, 2021 Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired Psychedelic Drug Candidates
PressAugust 20, 2021 Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms
PressAugust 19, 2021 Cybin Files Two Additional International Patent Applications in Support of the Company’s Research Phase Programs
PressAugust 17, 2021 Mydecine Innovations finishes 2Q with C$7M in cash after busy research period pinpoints four new lead drug candidates
PressAugust 17, 2021 Beckley Psytech completes oversubscribed $80m fundraise to develop portfolio of psychedelic medicine breakthroughs
PressAugust 16, 2021 atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update
PressAugust 13, 2021 Core One Labs’ Clinics Submit Application to Treat Patient With Psilocybin Psychedelic-Assisted Therapy
PressAugust 12, 2021 Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under the Symbol ‘AWKNF’ on August 12th
